📰 Registration Document News
Page 36 - Registration Document News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Registration Document. Real-time updates on events, politics, business and more.
October 25, 2023
Q3 2023 turnover : €126.2 million Stable third quarter due to the impact of restrictions put in place in Brazil Energy sales: +5%. Stability of production despite restrictions put in place,...
October 24, 2023
Approval of study design by French ANSM and Ethics Committee Recruitment of 12 patients expected to start in Q4 2023 in 4 French centersFirst study results expected in mid-2024 Lyon (France) et Cambridge (MA, US),
October 24, 2023
Investegate announcements from PHAXIAM Therapeutics obtains authorizations to launch its phase 1 study in endocarditis infections caused by Staphylococcus aureus
October 23, 2023
Lyon (France) et Cambridge (MA, US), October 23, 2023, at 10:05 pm CEST – PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM), a biopharmaceutical company developing innovative treatments for resistant bacterial
October 20, 2023
EQS-News: ABIVAX / Key word: Miscellaneous Abivax announces trading resumption of its ordinary shares on Euronext Paris 20.10.2023 / 15:45 CET/CEST The issuer is...
October 20, 2023
NANTERRE OCTOBER 20, 2023 THIRD-QUARTER 2023 SALES STRONG OUTPERFORMANCE AND ORGANIC GROWTH, ROBUST ORDER INTAKE MAINTAINING FOCUS ON CASH GENERATION WHILE...
October 20, 2023
Abivax Announces Temporary Trading Halt of its Ordinary Shares on Euronext ...
October 20, 2023
NOTICE OF NOTEHOLDERS MEETING THIS NOTICE IS IMPORTANT AND REQUIRES THE IMMEDIATE ATTENTION OF NOTEHOLDERS. IF NOTEHOLDERS ARE IN ANY DOUBT AS TO THE ACTION THEY...
October 20, 2023
EQS-News: ABIVAX / Key word: Temporary Suspension Abivax announces temporary trading halt of its ordinary shares on Euronext Paris 20.10.2023 / 08:45 CET/CEST The...